| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC371 | IgG1 kappa | ELISA; IHC; FC; IP; IF; FuncS | |||
| V3S-0522-YC8245 | Human erb-b2 receptor tyrosine kinase 2 | IgG | WB; IF; FuncS | ||
| V3S-0522-YC916 | IgG1 kappa | ELISA; FuncS | |||
| V3S-0622-YC1491 | IgG1 | WB | |||
| V3S-0622-YC1501 | Recombinant human ErbB2/Her2 Fc Chimera Protein | IgG | WB | ||
| V3S-0622-YC3250 | IgG | ELISA | |||
| V3S-0723-FY207 | IgG | ELISA | |||
| V3S-0723-FY59 | IgG | ELISA; FuncS | |||
| V3S-0822-YC2973 | IgG | ELISA | |||
| V3S-0822-YC2980 | IgG | ELISA; FC | |||
| V3S-0822-YC2982 | IgG1 | ELISA | |||
| V3S-1022-YC1287 | IgG | FuncS; WB; FC; Activ; ELISA | |||
| V3S-1022-YC1288 | IgG | Activ; FuncS; WB; FC; ELISA | |||
| V3S-1022-YC1717 | IgG | ELISA | 0.13-0.33 nM | ||
| V3S-1022-YC315 | IgG | ELISA; FC; WB | 8 nM | ||
| V3S-1022-YC55 | IgG | ELISA | |||
| V3S-1022-YC948 | IgG | IF; FC; ELISA; Activ | |||
| V3S-1022-YC949 | IgG | Activ; WB; ELISA | |||
| V3S-1022-YC950 | IgG | ELISA | |||
| V3S-1222-YC2125 | IgG | ELISA; FC | |||
| V3S-1222-YC862 | IgG | ELISA |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Erb-b2 receptor tyrosine kinase 2. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Isotype | IgG1, κ |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; IHC; FC; IP; IF; FuncS |
| Application Notes | The antibody is recommended for detection of ERBB2 by ELISA, IHC, FC, IP, IF, FuncS assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | ERBB2 |
| Alternative Name | Erb-B2 Receptor Tyrosine Kinase 2; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2; Tyrosine Kinase-Type Cell Surface Receptor HER2; Neuro/Glioblastoma Derived Oncogene Homolog; Human Epidermal Growth Factor Receptor 2; Metastatic Lymph Node Gene 19 Protein; Proto-Oncogene C-ErbB-2; Proto-Oncogene Neu; EC 2.7.10.1; P185erbB2; MLN 19; HER2; NGL; NEU; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (Neuro/Glioblastoma Derived Oncogene Homolog); V-Erb-B2 Erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/Glioblastoma Derived Oncogene Homolog; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncoprotein 2; Neuroblastoma/Glioblastoma Derived Oncogene Homolog; C-Erb B2/Neu Protein; CD340 Antigen; HER-2/Neu; Herstatin; EC 2.7.10; CD340; HER-2; MLN19; TKR1 |
| Gene ID | 2064 |
| UniProt | P04626 |
| Research Area | Signal Pathway |
| Related Disease | Cancers |
